Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapleural urokinase for drainage of multi-septated malignant pleural effusion
ISRCTN12852177Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Sep 2009
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised trial in malignant pleural effusion (MPE) comparing Urokinase arm with Placebo arm (2 arms). Primary endpoints: Change in breathlessness over 28 days and Pleurodesis failure within 28 days. Started Sep 2009; status: completed.
02
Drugs
urokinase
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on ISRCTN12852177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12852177.